DSpace JSPUI

1. BVS Saúde dos Povos Indígenas
2. Doenças Infecto-Parasitárias (DIP)
3. DIP - Artigos de Periódicos

Title:	Clinical characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil
Authors:	Sardinha, Daniele Melo Lima, Karla Valéria Batista Ferreira, Ana Lúcia da Silva Garcez, Juliana Conceição Dias Ueno, Thalyta Mariany Rêgo Lopes Rodrigues, Yan Corrêa Santos, Anderson Lineu Siqueira dos Loiola, Rosane do Socorro Pompeu Guimarães, Ricardo José de Paula Souza e Lima, Luana Nepomuceno Gondim Costa
Keywords:	Brazil Indians, South American Health of Indigenous Peoples Coronavirus Infections SARS-CoV-2
metadata.dc.subject.es:	Epidemiologic Studies
DeCS:	Brasil Índios Sul-Americanos Estudos Epidemiológicos Saúde de Populações Indígenas Infecções por Coronavirus Síndrome Respiratória Aguda
Issue Date:	27-Oct-2020
Publisher:	medRxiv
Citation:	SARDINHA, D. M. et al. Clinical characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil. medRxiv, p. 2020.10.24.20218701, 1 jan. 2020. Disponível em: https://www.medrxiv.org/content/10.1101/2020.10.24.20218701v3. Acesso em: 18 out. 2021
Description:	The indigenous people of Brazil present several cases and deaths, affecting 158 peoples, with high vulnerability and limited access to health services. Objective: Investigate the clinical characteristics of severe acute respiratory syndrome by COVID-19 in indigenous peoples of Brazil. Method :The epidemiological, cross-sectional, and analytical study, from the data of the platform opendataSUS referring to the SIVEP-GRIPE in the period of 01/01/2020 until 31/08/2020. Profile variables, signs and symptoms, and risk factors/comorbidities. The data were analyzed by Bioestat 5.3. Results :1,207 cases and 470 deaths. Profile: male gender (59.48%) mean age 53. Signs and symptoms: fever (74.23%), cough (77.71%), sore throat (35.62%), dyspnea (69.34%), respiratory discomfort (62.80%), O2 saturation <95% (56.42%); and associated with mortality: dyspnea (80.0%) and O2 saturation <95% (69.36%). Risk factors and comorbidities (45.89%) were associated with deaths (54.04%). Comorbidities: Chronic Cardiovascular Disease (18.97%) and Diabetes Mellitus (18.97%), and associated with deaths: Chronic Cardiovascular Disease (24.46%). There was significance in the survivors vaccinated for influenza (26.18%). Conclusion : The public and health policies of Brazil should be directed to control the dissemination of COVID-19 in this population, that COVID-19 evolves in the same intensity, however, the indigenous have vulnerabilities that can enhance the impact of the pandemic in this population.
metadata.dc.identifier.doi:	10.1101/2020.10.24.20218701
Copyright:	open access
metadata.dc.description.type:	Pré-print
Appears in Collections:	DIP - Artigos de Periódicos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.